Table 3.
Multivariate logistic regression for outcomes after SARS-CoV-2 infection
| Hospital admission | ICU admission | Mortality | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
| Age (per year) | 1.01 (1.01–1.02) | <.001 | 0.97 (0.96–0.98) | <.001 | 1.05 (1.04–1.06) | <.001 |
| Sex (male) | 1.21 (1.01–1.46) | .034 | – | – | – | – |
| KRT (KT) | 1.81 (1.46–2.23) | <.001 | 2.90 (2.28–3.68) | <.001 | – | – |
| Lymphopenia (yes) | 5.58 (4.64–6.65) | <.001 | 3.23 (2.16–4.82) | <.001 | 1.98 (1.48–2.64) | <.001 |
| Pneumonia (yes) | 50.7 (39.4–65.4) | <.001 | 16.9 (8.64–33.4) | <.001 | 2.87 (2.15–3.83) | <.001 |
| KRT vintage (month) | – | – | 0.99 (0.99–0.99) | .008 | – | – |
| SARS-CoV-2 wave (first) | 1.57 (1.28–1.93) | <.001 | 0.43 (0.34–0.54) | <.001 | – | – |
| ICU rejection (yes) | – | – | – | – | 13.1 (9.81–17.5) | <.001 |
Models adjusted for diabetic kidney disease. KRT, kidney replacement therapy; KT, kidney transplant; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; OR (95% CI): odds ratio (95% confidence interval).